HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU cosmetics regulation

This article was originally published in The Rose Sheet

Executive Summary

Seventh Amendment to the Cosmetics Directive "provides an opportunity for proactive corporations to move ahead with new products and gain a market share in a global economy," according to a Citizens Advisers, Inc. report examining the impact of EU cosmetics regulations. Conversely, companies that do not reformulate to meet EU standards "could face reduced market demand, potential liabilities and damaged reputation," financial firm asserts. In light of recent publicity surrounding potentially harmful cosmetic ingredients, U.S. consumers are likely to "demand the same level of safety as Europeans," report adds. The Seventh Amendment, adopted in 2003, calls for a phased-in ban on animal testing for cosmetics and restricts the use of substances that have been found to be carcinogenic, mutagenic or reproductive toxins (1"The Rose Sheet" Feb. 17, 2003, In Brief)...

You may also be interested in...

EU animal testing

Council of Ministers adopts Seventh Amendment to the Cosmetics Directive banning animal testing on cosmetics. Legislation, passed during the Council's Jan. 27-28 meeting, is in line with joint text agreed upon in conciliation with European Parliament, which passed the amendment Jan. 15. Long-debated marketing/testing ban passed conciliation in November prohibiting testing of cosmetics on animals immediately when alternative methods are available and imposing a six-year deadline for most tests when validated alternatives are not yet available (1"The Rose Sheet" Nov. 25, 2002, p. 6)...

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts